Professor Ariane Herrick 

2012

• Bossini-Castillo, et al (2012). A GWAS follow-up study reveals the association of IL12RB2 gene with Systemic Sclerosis in Caucasian populations. Hum Mol Genet, 21(4), 926-933. eScholarID:137408 | PMID:22076442 | DOI:10.1093/hmg/ddr522
• Broen, J., Bossini-Castillo, L., Van Bon, L., Vonk, M., Knaapen, H., Beretta, L., Rueda, B., Hesselstrand, R., Herrick, A., Worthington, J., Hunzelman, N., Denton, C., Fonseca, C., Riemekasten, G., Kiener, H., Scorza, R., Simeon, C., Ortego-Centeno, N., Spanish_Scleroderma_Group, S., Gonzalez-Gay, M., Airo, P., Coenen, M., Martin, J. & Radstake, T (2012). A rare polymorphism in Toll Like Receptor 2 is associated with systemic sclerosis phenotype and increases production of inflammatory mediators. Arthritis Rheum, 64(1), 264-271. eScholarID:131397 | PMID:21905008 | DOI:10.1002/art.33325
• Broen, J., Dieude, P., Vonk, M., Beretta, L., Carmona, F., Herrick, A., Worthington, J., Hunzelmann, N., Riemekasten, G., Kiener, H., Scorza, R., Simeon, C., Fonollosa, V., Carreira, P., Ortego-Centeno, N., Gonzalez-Gay, M., Airo, P., Coenen, M., Tsang, K., Aliprantis, A., Martin, J., Allanore, Y. & Radstake, T (2012). Polymorphisms in the interleukin 4, interleukin 13, and corresponding receptor genes are not associated with systemic sclerosis and do not influence gene expression. J Rheumatol, 39(1), 112-118. eScholarID:137406 | PMID:22045834 | DOI:10.3899/jrheum.110235

2011

• Baildam, E., Ennis, H., Foster, H., Shaw, L., Chieng, A., Kelly, J., Herrick, A. & Richards, H (2011). Influence of Childhood Scleroderma on Physical Function and Quality of Life. J Rheumatol, 38(1), 167-173. eScholarID:93946 | PMID:21041272 | DOI:10.3899/jrheum.100447
• Binymin, K., Herrick, A., Carlson, G. & Hopkins, S (2011). The effect of disease activity on body composition and resting energy expenditure in patients with rheumatoid arthritis. J Inflamm Res, 4, 61-6. eScholarID:137409 | PMID:22096370 | DOI:10.2147/JIR.S16508
• Bossini-Castillo, et al (2011). A replication study confirms the association of TNFSF4 (OX40L) polymorphisms with systemic sclerosis in a large European cohort. Ann Rheum Dis, 70(4), 638-641. eScholarID:103644 | PMID:21187296 | DOI:10.1136/ard.2010.141838
• Bossini-Castillo, et al (2011). Confirmation of association of the macrophage migration inhibitory factor gene with systemic sclerosis in a large European population. Rheumatology (Oxford), 50(11), 1976-1981. eScholarID:134290 | PMID:21875883 | DOI:10.1093/rheumatology/ker259
• Carmona, et al (2011). Association of a non-synonymous functional variant of the ITGAM gene with systemic sclerosis. Ann Rheum Dis, 70(11), 2050-2052. eScholarID:123234 | PMID:21571730 | DOI:10.1136/ard.2010.148874
• Diaz-Gallo, et al (2011). Analysis of the influence of PTPN22 gene polymorphisms in systemic sclerosis. Ann Rheum Dis, 70(3), 454-462. eScholarID:98940 | PMID:21131644 | DOI:10.1136/ard.2010.130138
• Fransen, J., Johnson, S., van den Hoogen, F., Baron, M., Allanore, Y., Carreira, P., Czirják, L., Denton, C., Distler, O., Furst, D., Gabrielli, A., Herrick, A., Inanc, M., Kahaleh, B., Kowal-Bielecka, O., Medsger, T., Mueller-Ladner, U., Riemekasten, G., Sierakowski, S., Valentini, G., Veale, D., Vonk, M., Walker, U., Chung, L., Clements, P., Collier, D., Csuka, M., Jimenez, S., Merkel, P., Seibold, J., Silver, R., Steen, V., Tyndall, A., Matucci-Cerinic, M., Pope, J. & Khanna, D (2011). Items for developing revised classification criteria in systemic sclerosis: Results of a consensus exercise with the ACR/EULAR working committee for classification criteria in systemic sclerosis. Arthritis Care Res (Hoboken), [Epub ahead of print], eScholarID:137407 | PMID:22052558 | DOI:10.1002/acr.20679
• Gliddon, A., Doré, C., Dunphy, J., Betteridge, Z., McHugh, N., Maddison, P. & QUINS_Trial_Study_Group, Q (2011). Antinuclear antibodies and clinical associations in a british cohort with limited cutaneous systemic sclerosis. J Rheumatol, 38(4), 702-5. eScholarID:134288 | PMID:21239752 | DOI:10.3899/jrheum.100754
• Herrick, A (2011). Contemporary management of Raynaud's phenomenon and digital ischaemic complications. Curr Opin Rheumatol, 23(6), 555-561. eScholarID:131468 | PMID:21885977 | DOI:10.1097/BOR.0b013e32834aa40b
• Herrick, A., Ennis, H., Bhushan, M., Silman, A. & Baildam, E (2011). Clinical features of childhood localized scleroderma in an incidence cohort. Rheumatology (Oxford), 50(10), 1865-1868. eScholarID:126791 | PMID:21729934 | DOI:10.1093/rheumatology/ker142
• Herrick, A., van den Hoogen, F., Gabrielli, A., Tamimi, N., Reid, C., O'Connell, D., Vázquez-Abad, M. & Denton, C (2011). Modified-release sildenafil reduces Raynaud's phenomenon attack frequency in limited cutaneous systemic sclerosis. Arthritis Rheum, 63(3), 775-82. eScholarID:120039 | PMID:21360507 | DOI:10.1002/art.30195
• Hofstee, H., Serné, E., Roberts, C., Hesselstrand, R., Scheja, A., Moore, T., Wildt, M., Manning, J., Vonk Noordegraaf, A., Voskuyl, A. & Herrick, A (2011). A multicentre study on the reliability of qualitative and quantitative nail-fold videocapillaroscopy assessment. Rheumatology (Oxford), [Epub ahead of print], eScholarID:155348 | PMID:22190689 | DOI:10.1093/rheumatology/ker403
• Martin, et al (2011). The autoimmune disease-associated IL2RA locus is involved in the clinical manifestations of systemic sclerosis. Genes Immun, [Epub ahead of print], eScholarID:134291 | PMID:22012429 | DOI:10.1038/gene.2011.72
• Murray, A., Feng, K., Moore, T., Allen, P., Taylor, C. & Herrick, A (2011). Preliminary clinical evaluation of semi-automated nailfold capillaroscopy in the assessment of patients with Raynaud's phenomenon. Microcirculation, 18(6), 440-447. eScholarID:121629 | PMID:21466606 | DOI:10.1111/j.1549-8719.2011.00104.x
• Murray, A., Moore, T. & Herrick, A (2011). Clinical Images: Systemic sclerosis-related telangiectases. Arthritis Rheum, 63(2), 572. eScholarID:134289 | PMID:20954193 | DOI:10.1002/art.30079
• Shah,P.; Murray,A.K.; Moore,T.L.; Herrick,A.L. (2011). Effects of iloprost on microvascular structure assessed by nailfold videocapillaroscopy: a pilot study. J.Rheumatol, 38(9), 2079-2080. eScholarID:155349

2010

• Alizadeh, B., Broen, J., Rueda, B., Hesselstrand, R., Wuttge, D., Simeon, C., Ortego-Centeno, N., Gonzalez-Gay, M., Pros, A., Herrick, A., Worthington, J., Denton, C., Fonseca, C., Riemekasten, G., Vonk, M., van den Hoogen, F., Guiducci, S., Matucci-Cerinic, M., Scorza, R., Beretta, L., Airó, P., Coenen, M., Martin, J., Koeleman, B. & Radstake, T (2010). Functional Variants of Fc Gamma Receptor (FCGR2A) and FCGR3A Are Not Associated with Susceptibility to Systemic Sclerosis in a Large European Study (EUSTAR). J Rheumatol, 37(8), 1673-1679. eScholarID:85018 | PMID:20551103 | DOI:10.3899/jrheum.091259
• Chikura, B., Moore, T., Manning, J., Vail, A. & Herrick, A (2010). Thumb involvement in Raynaud's Phenomenon as an indicator of underlying connective tissue disease. J Rheumatol, 37(4), 783-786. eScholarID:78096 | PMID:20194444 | DOI:10.3899/jrheum.091117
• Herrick, A. & Cutolo, M (2010). Clinical implications from capillaroscopic analysis in patients with Raynaud's phenomenon and systemic sclerosis. Arthritis Rheum, 62(9), 2595-604. eScholarID:103538 | PMID:20506306 | DOI:10.1002/art.27543
• Herrick, A., Ennis, H., Bhushan, M., Silman, A. & Baildam, E (2010). Incidence of childhood linear scleroderma and systemic sclerosis in the UK and Ireland. Arthritis Care Res (Hoboken), 62(2), 213-8. eScholarID:78097 | PMID:20191520 | DOI:10.1002/acr.20070
• Herrick, A., Lunt, M., Whidby, N., Ennis, H., Silman, A., McHugh, N. & Denton, C (2010). Observational study of treatment outcome in early diffuse cutaneous systemic sclerosis. J Rheumatol, 37(1), 116-24. eScholarID:76329 | PMID:19955050 | DOI:10.3899/jrheum.090668
• Herrick, A., Moore, T., Murray, A., Whidby, N., Manning, J., Bhushan, M. & Vail, A (2010). Nail-fold capillary abnormalities are associated with anti-centromere antibody and severity of digital ischaemia. Rheumatology (Oxford), 49(9), 1776-82. eScholarID:103539 | PMID:20538680 | DOI:10.1093/rheumatology/keq139
• Mercer, L., Moore, T., Chinoy, H., Murray, A., Vail, A., Cooper, R. & Herrick, A (2010). Quantitative nailfold video capillaroscopy in patients with idiopathic inflammatory myopathy. Rheumatology (Oxford), 49(9), 1699-1705. eScholarID:85258 | PMID:20483911 | DOI:10.1093/rheumatology/keq051
• Moore, T., Roberts, C., Murray, A., Helbling, I. & Herrick, A (2010). Reliability of dermoscopy in the assessment of patients with Raynaud's phenomenon. Rheumatology (Oxford), 49(3), 542-7. eScholarID:78099 | PMID:20028729 | DOI:10.1093/rheumatology/kep408
• Radstake, et al (2010). Genome-wide association study of systemic sclerosis identifies CD247 as a new susceptibility locus. Nat Genet, 42(5), 426-9. eScholarID:82914 | PMID:20383147 | DOI:10.1038/ng.565
• Sadik, H., Moore, T., Vail, A., Murray, A., Anderson, M., Blann, A. & Herrick, A (2010). Lack of effect of 8 weeks atorvastatin on microvascular endothelial function in patients with systemic sclerosis. Rheumatology (Oxford), 49(5), 990-996. eScholarID:78098 | PMID:20159906 | DOI:10.1093/rheumatology/keq003

2009

• Davies, C., Herrick, A., Cordingley, L., Freemont, A. & Jeziorska, M (2009). Expression of advanced glycation end products and their receptor in skin from patients with systemic sclerosis with and without calcinosis. Rheumatology (Oxford), 48(8), 876-82. eScholarID:94983 | PMID:19542215 | DOI:10.1093/rheumatology/kep151
• Herrick AL, Roberts C, Tracey A, Silman A, Anderson M, Goodfield M, McHugh N, Muir L, Denton C. (2009). Lack of agreement between rheumatologists in defining digital ulceration in systemic sclerosis. Arthritis Rheum, 60( 3), 878-82. eScholarID:1d19119 | DOI:10.1002/art.24333
• Ingram M, O'Neill TW, Herrick AL. (2009). Vitamin C for preventing complex regional pain syndrome (type I) after wrist fractures in adults (Protocol). Cochrane Database of Systematic Reviews, Issue 2, eScholarID:1d21578 | DOI:10.1002/14651858.CD007817
• Moore, T., Vij, S., Murray, A., Bhushan, M., Griffiths, C. & Herrick, A (2009). Pilot study of dual-wavelength (532 and 633 nm) laser Doppler imaging and infrared thermography of morphoea. Br J Dermatol, 160(4), 864-7. eScholarID:82917 | PMID:19067705 | DOI:10.1111/j.1365-2133.2008.08933.x
• Murray AK, Moore TL, Griffiths CEM, Herrick AL. (2009). An investigation into the blood-flow characteristics of telangiectatic skin lesions in systemic sclerosis using dual-wavelength laser Doppler imaging. Clin Exp Dermatol, 34(5), 618-620. eScholarID:1d19239 | DOI:10.1111/j.1365-2230.2008.03170.x
• Murray AK, Moore TL, Manning JB, Taylor C, Griffiths CEM, Herrick AL. (2009). Non-invasive imaging techniques in the assessment of scleroderma-spectrum disorders. Arthritis Care and research, 61(8), 1103 - 1111. eScholarID:1d21840 | DOI:10.1002/art.24645
• Rueda, B, Simeon, C, Hesselstrand, R, Herrick, AL, Worthington, J, Ortego-Centeno, N, Riemekasten, G, Fonollosa, V, Vonk, M, van den Hoogen, F, Sanchez-Román, J, Aguirre-Zamorano, M, García-Portales, R, Pros, A, Camps, M, Gonzalez-Gay, M, Coenen, M, Lambert, N, Nelson, J, Radstake, T, Martin, J. (2009). A large multicenter analysis of CTGF -945 promoter polymorphism does not confirm association with Systemic Sclerosis susceptibility or phenotype. Ann Rheum Dis, 68(10), 1618-1620. eScholarID:1d18215 | DOI:10.1136/ard.2008.100180
• Tailor R, Gupta A, Herrick AL, Kwartz J. (2009). Ocular manifestations of scleroderma. Survey of Opthalmology, 54, 292-304. eScholarID:1d21849 | DOI:10.1016/j.survophthal.2008.12.007

2008

• Brown M, Teubner A, Shaffer J, Herrick AL. (2008). Home parenteral nutrition--an effective and safe long-term therapy for systemic sclerosis-related intestinal failure. Rheumatology (Oxford), 47 (2), 176-9. eScholarID:1d16930
• Chikura B, Moore T, Manning J, Vail A, Herrick AL. (2008). Sparing of the thumb in Raynaud's phenomenon. Rheumatology (Oxford), 47 (2), 219-21. eScholarID:1d16928
• Herrick AL. (2008). Systemic sclerosis: an update for clinicians. Br J Hosp Med (Lond), 69( 8), eScholarID:1d18488
• Merkel, P, Silliman, N, Denton, C, Furst, D, Khanna, D, Emery, P, Hsu, V, Streisand, J, Polisson, R, Akesson, A, Coppock, J, van den Hoogen, F, Herrick, AL, Mayes, M, Veale, D, Seibold, J, Black, C, Korn, J, CAT-192 Research Group, Scleroderma Clinical Trials Consortium. (2008). Validity, reliability, and feasibility of durometer measurements of scleroderma skin disease in a multicenter treatment trial. Arthritis Rheum, 59 (5), 699-705. eScholarID:1d18237 | DOI:10.1002/art.23564
• Murray, A., Moore, T., King, T. & Herrick, A (2008). Vasodilator iontophoresis a possible new therapy for digital ischaemia in systemic sclerosis? Rheumatology (Oxford), 47(1), 76-9. eScholarID:85135 | PMID:18077494 | DOI:10.1093/rheumatology/kem314
• Pushpakom SP, Herrick AL, Kumar S, Worthington J. (2008). Polymorphisms in COL15 Gene Are Not Associated with Systemic Sclerosis. J Rheumatol, 35(2), 251-3. eScholarID:1d16929
• Chitale S, Al-Mowallad AF, Wang Q, Kumar S, Herrick AL. (2008). High circulating levels of VEGF-C suggest abnormal lymphangiogenesis in systemic sclerosis. Rheumatology, 47, 1727-1728. eScholarID:17d554
• Chitale S, Watson J, Herrick AL. (2008). Autologous skin grafting - a limb saving procedure in a patient with diffuse cutaneous systemic sclerosis. Rheumatology, 47, 379-380. eScholarID:17d746
• Herrick AL. (2008). Diagnosis and management of scleroderma peripheral vascular disease. Rheumatic Disease Clinics of North America, eScholarID:17d804

2007

• Gorodkin RE, Herrick AL. (2007). Reflex sympathetic dystrophy (complex regional pain syndrome type I). Rheumatology. Fourth Edition. Elsevier Science. eScholarID:3d338
• Anderson ME, Moore TL, Lunt M, Herrick AL. (2007). The 'distal-dorsal difference': a thermographic parameter by which to differentiate between primary and secondary Raynaud's phenomenon. Rheumatology (Oxford), 46(3), 533-8. eScholarID:1d14366
• CA Denton, PA Merkel, DE Furst, V Khanna, Emery, P, VM Hsu, N Silliman, J Streisand, J Powell, A Akesson, A Coppock, F van den Hoogen, Herrick, AL, MD Mayes, D Veale, S Ledbetter, JH Korn, CM Black, JR Seibold. (2007). Recombinant human anti-TGFbeta1 antibody therapy in systemic sclerosis: a multicentre, randomised, placebo-controlled Phase I/II trial of CAT-192. Arthritis and Rheumatism, 56(1), 323-333. eScholarID:1d15034 | DOI:10.1002/art.22289
• Gazi, H, Pope, J, Clements, P, Medsger, T, Martin, R, Merkel, P, Kahaleh, B, Wollheim, F, Baron, M, Csuka, M, Emery, P, Belch, J, Hayat, S, Lally, E, Korn, J, Czirjak, L, Herrick, AL, Voskuyl, A, Bruehlmann, P, Inanc, M, Furst, D, Black, C, Ellman, M, Moreland, L, Rothfield, N, Hsu, V, Mayes, M, McKown, K, Krieg, T, Siebold, J. (2007). Outcome measurements in scleroderma: results from a delphi exercise. J Rheumatol, 34( 3), 501-9. eScholarID:1d15803
• Gliddon, A, Doré, C, Black, C, McHugh, N, Moots, R, Denton, C, Herrick, AL, Barnes, T, Camilleri, J, Chakravarty, K, Emery, P, Griffiths, B, Hopkinson, N, Hickling, P, Lanyon, P, Laversuch, C, Lawson, T, Mallya, R, Nisar, M, Rhys-Dillon, C, Sheeran, T, Maddison, P. (2007). Prevention of vascular damage in scleroderma and autoimmune Raynaud's phenomenon: a multicenter, randomized, double-blind, placebo-controlled trial of the angiotensin-converting enzyme inhibitor quinapril. Arthritis Rheum, 56( 11), 3837-46. eScholarID:1d21837 | DOI:10.1002/art.22965
• Rice, G, Newman, WG, Dean, J, Patrick, T, Parma, R, Flintoff, K, Robins, P, Harvey, S, Hollis, T, O'Hara, A, Herrick, AL, Bowden, AP, Perrino, FW, Lindahl, T, Barnes, DE, Crow, YJ. (2007). Heterozygous mutations in TREX1 cause familial chilblain lupus and dominant Aicardi-Goutieres syndrome. American Journal of Human Genetics, 80(4)(4), eScholarID:1d15528
• Moore T, Vail A, Herrick AL. (2007). Assessment of digital vascular structure and function in response to bosentan in patients with systemic sclerosis-related Raynaud's phenomenon. Rheumatology (Oxford), 46(2), 363-4. eScholarID:17d674

2006

• Herrick AL. (2006). Systemic sclerosis. The Year in Rheumatic Disorders. Volume 5. Clinical Publishing Services, Oxford. eScholarID:3d337
• Davies, C., Jeziorska, M., Freemont, A. & Herrick, A (2006). Expression of osteonectin and matrix Gla protein in scleroderma patients with and without calcinosis. Rheumatology (Oxford), 45(11), 1349-55. eScholarID:85134 | PMID:17050587 | DOI:10.1093/rheumatology/kei277
• Davies, C., Jeziorska, M., Freemont, A. & Herrick, A (2006). The differential expression of VEGF, VEGFR-2, and GLUT-1 proteins in disease subtypes of systemic sclerosis. Hum Pathol, 37(2), 190-7. eScholarID:85133 | PMID:16426919 | DOI:10.1016/j.humpath.2005.10.007
• Hoyles, R, Ellis, R, Wellsbury, J, Lees, B, Newlands, P, Goh, N, Roberts, C, Desai, S, Herrick, AL, McHugh, N, Foley, N, Pearson, S, Emery, P, Veale, D, Denton, C, Wells, A, Black, C, du Bois, R. (2006). A multicenter, prospective, randomized, double-blind, placebo-controlled trial of corticosteroids and intravenous cyclophosphamide followed by oral azathioprine for the treatment of pulmonary fibrosis in scleroderma. Arthritis Rheum, 54( 12), eScholarID:1d14369
• Murray AK, Moore TL, King TA, Herrick AL. (2006). Abnormal microvascular response is localised to the digits in patients with systemic sclerosis. Arthritis and Rheumatism, 54, 1952-1960. eScholarID:1d12903 | DOI:10.1002/art.21911

2005

• Herrick AL, McColl K. (2005). Acute intermittent porphyria. Best Pract Res Clin Gastroenterol, 19( 2), 235-49. eScholarID:1d21843 | DOI:10.1016/j.bpg.2004.10.006
• Herrick AL. (2005). Pathogenesis of Raynaud's phenomenon. Rheumatology (Oxford), 44( 5), 587-96. eScholarID:1d21844 | DOI:10.1093/rheumatology/keh552
• Murray AK, Herrick AL, Gorodkin RE, Moore TL, King T. (2005). Possible therapeutic use of vasodilator iontophoresis. Microvascular Research, 69, 89-94. eScholarID:1d11092 | DOI:10.1016/j.mvr.2005.01.005
• Murray AK, Herrick AL, Moore TL, King TA, Griffiths CEM. (2005). Dual wavelength (532 and 633nm) laser Doppler imaging of plaque psoriasis. British Journal of Dermatology, 152, 1182-1186. eScholarID:1d12853 | DOI:10.1111/j.1365-2133.2005.06479.x
• Shetty S, Moore TL, Jackson SK, Brettle D, Herrick AL. (2005). A pilot study of acetic acid iontophoresis and ultrasound in the treatment of systemic sclerosis-related calcinosis. Rheumatology, 44, 536-538. eScholarID:1d11094

2004

• Herrick AL. (2004). Nervous System. Systemic scherosis (2nd edition). Philadelphia: Academic Press. eScholarID:3d439
• Herrick AL. (2004). Systemic sclerosis. The Year in Rheumatic Disorders. Oxford: Academic Press. eScholarID:3d440
• Anderson ME, Moore T, Lunt M, Herrick AL. (2004). Digital iontophoresis of vasoactive substances as measured by laser Doppler imaging - a non-invasive technique by which to measure microvascular dysfunction in Raynaud's phenomenon. Rheumatology, 43, 8, 986-991. eScholarID:1d8185 | DOI:10.1093/rheumatology/keh244
• Herrick AL, C Hutchinson. (2004). Vascular imaging. Best Practice and Research Clinical Rheumatology, 18, 957-979. eScholarID:1d9646
• J H Korn, Herrick AL, C Black. (2004). Digital ulcers in systemic sclerosis. Prevention by treatment with bosentan, an oral endothelin receptor antagonist. Arthritis and Rheumatism, 50, 3985-3993. eScholarID:1d9636
• Murray AK, Herrick AL, King T. (2004). Laser Doppler imaging: a developing technique for application in the rheumatic diseases. Rheumatology, 43, 1210-1218. eScholarID:1d12851
• Murray AK, R E Gorodkin, T L Moore, R J Gush, Herrick AL, T A King. (2004). Comparison of red and green laser Doppler imaging of blood flow. Lasers in Medicine and Surgery, 35, 191-200. eScholarID:1d9635 | DOI:10.1002/lsm.20085
• R Gorodkin, Moore T, Herrick AL. (2004). Assessment of endothelial function in complex regional pain syndrome type 1 using iontophoresis and laser Doppler imaging. Rheumatology, 43, 727-730. eScholarID:1d7903
• Richards HL, Herrick AL, Kerry Griffin, P D H Gwilliam, D G Fortune. (2004). Psychological adjustment to systemic sclerosis - exploring the association of disease factors, functional ability, body related attitudes and fear of negative evaluation. Psychology, Health and Medicine, 9, eScholarID:1d9634
• Gorodkin RE, Leahy B C, Neary D, Herrick AL. (2004). Coexistence of systemic sclerosis and multiple sclerosis. Journal of Neurology, 251, 1524-5. eScholarID:17d359
• H Sari-Houzel, Herrick AL, P R Chadwick, LTS Muir, Denning DW. (2004). Mycobacterium chelonae finger infection associated with Raynaud's phenomenon. Annals of Rheumatic Diseases, 6, 1178-1179. eScholarID:17d198

2003

• Herrick AL. (2003). Raynaud's phenomenon. Vascular Surgery. Cases, Questions and Commentaries. Springer Verlag. eScholarID:3d961
• Herrick AL. (2003). Reflex sympathetic dystrophy (complex regional pain syndrome type I). Rhuematology. Elsevier Science. eScholarID:3d336
• Feng K, Allen P D, Moore T, Herrick AL, Taylor CJ. (2003). Automatic Capillary Measurement. Academic Press. eScholarID:2d1157
• Allen P D, Hillier VF, Moore T, Anderson ME, Taylor CJ, Herrick AL. (2003). Computer Based System for Acquisition and Analysis of Nailfold Capillary Images. Medical Image Understanding and Analysis, eScholarID:1d32761
• Clark S, Dunn G, MooreT, JaysonM, KingT.A, Herrick AL. (2003). Comparison of thermography and laser Doppler imaging in the assessment of Raynaud's phenomenon. Microvascular Research, 66, 1, 73-76. eScholarID:1d5366
• Herrick AL. (2003). Treatment of Raynaud's phenomenon: new insights and developments. Rheumatol Rep, 5, 2, 168-174. eScholarID:1d5614
• Jones GT, Herrick AL, WoodhamS.E, BaildamE.M, Macfarlane G, Silman AJ. (2003). Occurrence of Raynaud's Phenomenon in children ages 12-15 years: Prevalence and association with other common symptoms. Arthritis and Rheumatism, 48, 12, 3518-3521. eScholarID:1d5519 | DOI:10.1002/art.11340
• LingT.C, Herrick AL, AndrewS.M, BrammahT, Griffiths CEM. (2003). Keloidal scleroderma. Clinical and Experimental Dermatology, 28, 2, 171-173. eScholarID:1d25082
• MooreT.L, Lunt M, McManusB, AndersonM.E, Herrick AL. (2003). Seventeen-point dermal ultrasound scoring system--a reliable measure of skin thickness in patients with systemic sclerosis. Rheumatology, 42(12), 1559-63. eScholarID:1d5616 | DOI:10.1093/rheumatology/keg435
• Richards HL, Herrick AL, Griffin K, Gwilliam P, Loukes J, Fortune D. (2003). Systemic sclerosis: patients' perceptions of their condition. Arthritis Rheum, 49( 5), 689-96. eScholarID:1d9233
• AndersonM.E, MooreT.L, HollisS, Clark S, JaysonM.I, Herrick AL. (2003). Endothelial-dependent vasodilation is impaired in patients with systemic sclerosis, as assessed by low dose iontophoresis. Clinical and Experimental Rheumatology, 21, 3, 403. eScholarID:17d204

2002

• Anderson ME, Moore T, Hollis S, Jayson -M I V, King TA, Herrick AL. (2002). Digital vascular response to topical glyceryl trinitrate, as measured by laser Doppler imaging, in primary Raynaud's phenomenon and systemic sclerosis. Rheumatology, 41, 324-328. eScholarID:1d2811
• AndersonM.E, MooreT.L, HollisS, JaysonM.I, KingT.A, Herrick AL. (2002). Digital vascular response to topical glyceryl trinitrate, as measured by laser Doppler imaging, in primary Raynaud's phenomenon and systemic sclerosis. Rheumatology, 41, 3, 324-328. eScholarID:1d5607
• Harrison BJ, HutchinsonC.E, AdamsJ, BruceI.N, Herrick AL. (2002). Assessing periarticular bone mineral density in patients with early psoriatic arthritis or rheumatoid arthritis. Annals of the Rheumatic Diseases, 61, 11, 1007-1011. eScholarID:1d5609
• Harrison BJ, Silman AJ, Hider SL, Herrick AL. (2002). Cigarette smoking: a significant risk factor for digital vascular disease in patients with systemic sclerosis. Arthritis and Rheumatism, 46,12, 3312-3316. eScholarID:1d3752 | DOI:10.1002/art.10685
• Herrick AL, Worthington J. (2002). Genetic epidemiology: systemic sclerosis. Arthritis Res, 4, 3, 165-168. eScholarID:1d5612
• Anderson ME, Moore T, Hollis S, Clark S, Jayson -M I V, Herrick AL. (2002). Endothelial-dependent vasodilation is impaired in patients with systemic sclerosis, as assessed by low dose iontophoresis. Clinical and Experimental Rheumatology, eScholarID:17d71
• CasariS, HaeneyM, FarrandS, Herrick AL. (2002). Antineutrophil cytoplasmic antibodies a "Red Flag" in patients with systemic sclerosis. Journal of Rheumatology, 29, 12, 2666-2667. eScholarID:17d589

2001

• Allen P D, Taylor CJ, Herrick AL, Moore T. (2001). Microvascular Dynamics in the Nailfolds of Scleroderma Patients Studied Using Na-fluorescein Dye. eScholarID:2d1155
• Herrick AL, IllingworthK.J, HollisS, Gomez-ZumaqueroJ.M, TinahonesF.J. (2001). Antibodies against oxidized low-density lipoproteins in systemic sclerosis. Rheumatology, 40, 4, 401-405. eScholarID:1d5610
• Herrick AL, MatucciCerinic M. (2001). The emerging problem of oxidative stress and the role of antioxidants in systemic sclerosis. Clinical and Experimental Rheumatology, 19, 1, 4-8. eScholarID:1d5613
• Herrick AL, Rooney B, Finn J, Silman AJ. (2001). Lack of relationship between functional ability and skin score in patients with systemic sclerosis. Journal of Rheumatology, 28, 292-295. eScholarID:1d2848
• Herrick AL. (2001). Development of agents for the treatment of systemic sclerosis. Expert Opin Investig Drugs, 10, 7, 1255-1264. eScholarID:1d5611
• Sari-Kouzel H, Hutchinson CE, Middleton A, Webb F, Moore T, Griffin K, Herrick AL. (2001). Foot problems in patients with systemic sclerosis. Rheumatology, 40, 410-413. eScholarID:1d4059
• WanM.C, MooreT, HollisS, Herrick AL. (2001). Ankle brachial pressure index in systemic sclerosis: influence of disease subtype and anticentromere antibody. Rheumatology, 40, 10, 1102-1105. eScholarID:1d5617
• WutzlA.L, FoleyR.N, O'DriscollB.R, ReeveR.S, ChisholmR, Herrick AL. (2001). Microscopic polyangiitis presenting as pulmonary-renal syndrome in a patient with long-standing diffuse cutaneous systemic sclerosis and antibodies to myeloperoxidase. Arthritis and Rheumatism, 45, 6, 533-536. eScholarID:1d5618
• AhmedS, Herrick AL, O'DriscollB.R. (2001). Shrinking lung syndrome in patients without systemic lupus erythematosus: comment on the concise communication by Tavoni et al. Arthritis and Rheumatism, 44, 1, 243-245. eScholarID:17d896

2000

• Andrew JG, Herrick AL, Marsh DR. (2000). Musculoskeletal Medicine and Surgery. Churchill Livingstone. eScholarID:4d158
• Bhushan M, Moore TL, Herrick AL, Griffiths CEM. (2000). Nailfold video capillaroscopy in psoriasis. Br J Dermatol, 142( 6), 1171-6. eScholarID:1d21807
• Bukhari MAS, Hollis S, Moore T, Jayson -M I V, Herrick AL. (2000). Quantitation of microcirculatory abnormalities in patients with primary Raynaud's phenomenon and systemic sclerosis by video capillaroscopy. Rheumatology, 39, 506-512. eScholarID:1d2844
• Herrick AL, Hollis S, Schofield D, Rieley F, Blann A, Griffin K, Moore TL, Braganza J, Jayson M. (2000). A double-blind placebo-controlled trial of antioxidant therapy in limited cutaneous systemic sclerosis. Clin Exp Rheumatol, 18( 3), 349-56. eScholarID:1d21804
• Herrick AL, Moore T, Hollis S, Jayson -M I V. (2000). The influence of age on nailfold capillary dimensions in childhood. Journal of Rheumatology, 27, 979-800. eScholarID:1d2846
• Susol E, Rands A, Herrick AL, McHugh N, Barrett J, Ollier W, Worthington J. (2000). Association of markers for TGFbeta3, TGFbeta2 and TIMP1 with systemic sclerosis. Rheumatology (Oxford), 39( 12), 1332-6. eScholarID:1d21834

1999

• Allen P D, Taylor CJ, Herrick AL, Moore T. (1999). Image Analysis of Nailfold Capillary Patterns From Video Sequences. Academic Press. eScholarID:2d1468
• Anderson ME, Campbell F, Hollis S, Moore T, Jayson -M I V, Herrick AL. (1999). Non-invasive assessment of digital vascular reactivity in patients with primary Raynaud's phenomenon and systemic sclerosis. Clinical and Experimental Rheumatology, 17, 49-54. eScholarID:1d2813
• Black CM, Silman AJ, Herrick AL, Denton CP, Wilson H, Newman J, Pompon L, Shi-Wen X. (1999). Interferon-alpha does not improve outcome at one year in patients with diffuse cutaneous scleroderma: results of a randomized double-blind placebo controlled trial. Arthritis and Rheumatism, 42, 299-305. eScholarID:1d2840
• Clark S, Campbell F, Moore TL, Jayson M, King T, Herrick AL. (1999). Laser doppler imaging--a new technique for quantifying microcirculatory flow in patients with primary Raynaud's phenomenon and systemic sclerosis. Microvasc Res, 57( 3), 284-91. eScholarID:1d21797 | DOI:10.1006/mvre.1998.2124
• Clark S, Hollis S, Campbell F, Moore T, Jayson -M I V, Herrick AL. (1999). The 'distal-dorsal difference' as a possible predictor of secondary Raynaud's phenomenon. Journal of Rheumatology, 26, 1125-1128. eScholarID:1d2842
• Cotton S, Herrick AL, Jayson M, Freemont AJ. (1999). Endothelial expression of nitric oxide synthases and nitrotyrosine in systemic sclerosis skin. J Pathol, 189( 2), 273-8. eScholarID:1d10896
• Herrick AL, Hodgkiss R, Reed P, Weinkove C, Jayson M, Houston B. (1999). No significant effects of sodium aurothiomalate on haem metabolism and mixed function oxygenase activity in patients with rheumatoid arthritis. Clin Exp Rheumatol, 17( 4), 461-2. eScholarID:1d21800

1998

• Allen P D, Taylor CJ, Herrick AL, Moore T. (1998). Enhancement of Temporally Variable Features in Nailfold Capillary Patterns. Academic Press. eScholarID:2d1266
• Allen P D, Taylor CJ, Herrick AL, Moore T. (1998). Image Analysis of Nailfold Capillary Patterns. Academic Press. eScholarID:2d1411
• Herrick AL, Silman AJ. (1998). Manchester experience in establishing a part-time MSc course in rheumatology. British Journal of Rheumatology, 37, 1020-1022. eScholarID:1d28406

1995

• Herrick AL, Jayson MMI. (1995). Organ involvement: nervous system. Systemic Sclerosis. eScholarID:3d960

1991

• Herrick AL. (1991). Drugs in Joint Disease. Basic Pharmacology. Butterworth Heinemann. eScholarID:3d1094